FOXP3 was reported to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway (Yang et al., 2017), according to previous research studies on non-small cell lung cancer. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.